Company Search:
Advanced Search
Sponsored Links
Hangzhou Tigermed Consulting Co Ltd Company Snapshot
Hangzhou Tigermed Consulting Co Ltd operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hangzhou Tigermed Consulting Co Ltd with three other pharmaceutical manufacturers in Asia: Prodia Widyahusada Tbk PT of Indonesia (2018 sales of 1.60 trillion Indonesian Rupiahs [US$117.10 million] ), Dr. Lal PathLabs Ltd of India (10.57 billion Indian Rupees [US$149.45 million] of which 100% was Healthcare), and Falco Holdings Co Ltd which is based in Japan (45.96 billion Japanese Yen [US$418.25 million] of which 60% was Medical Test).

Sales Analysis. Hangzhou Tigermed Consulting Co Ltd reported sales of 2.30 billion Chinese Renmimbi (US$333.87 million) for the year ending December of 2018. This represents an increase of 36.4% versus 2017, when the company's sales were 1.69 billion Chinese Renmimbi. Sales at Hangzhou Tigermed Consulting Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 584%). Sales of Service saw an increase of 39.6% in 2018, from 1.65 billion Chinese Renmimbi to 2.30 billion Chinese Renmimbi. Not all segments of Hangzhou Tigermed Consulting Co Ltd experienced an increase in sales in 2018: sales of Other fell 93.5% to 2.63 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hangzhou Tigermed Consulting Co Ltd
  Stock Performance Chart for Hangzhou Tigermed Consulting Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 73.40
(Figures in Chinese Renmimbi)
1 Week 5.6%   13 Weeks 18.7%  
4 Weeks 7.1%   52 Weeks 157.2%  
Hangzhou Tigermed Consulting Co Ltd Key Data:
  Ticker: 300347 Country: China
  Exchanges: SZN Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 2,300,659,707
(Year Ending Jan 2019).
Employees: 3,898
  Currency: Chinese Renmimbi Market Cap: 55,022,517,352
  Fiscal Yr Ends: December Shares Outstanding: 749,625,577
  Share Type: A Gu Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.